AACE also recommends that longer-term studies are needed to assess the outcomes beyond 6-12 months.

The info accrual is after that downloaded and analyzed by the doctor and health care team and distributed to the patient. Related StoriesBariatric medical procedures improves weight, metabolic health and standard of living in adolescents after 3 yearsNew Cleveland Clinic research shows bariatric surgery is safe choice for managing type 2 diabetes in overweight or mildly obese patientsStudy discovers high prevalence of dehydration in the elderly living in UK care homes In the last few years, a number of randomized, controlled medical trials have already been undertaken to evaluate the effect of real-time CGM devices in the treating Type 1 diabetes, stated Irl B. Hirsch, MD, member of the American Association of Clinical Endocrinologists and co-chair of the CGM task force.Wysocki describes a demanding set of questions that require studies using modern systems to get a more complete understanding of the complex interactions involved. In one study, constant glucose monitoring data gathered from several women with type 2 diabetes led to the conclusion that greater glycemic variability could be associated with detrimental moods and lower quality of life, as described in the article ‘Will Glycemic Variability Influence Mood and Quality of Life?’ by Sue Penckofer, PhD, RN, Loyola University Chicago, Maywood, IL, and co-workers from University of Illinois at Chicago, Saint Mary’s College , mfmillstat, Ltd.